{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:54:29Z","timestamp":1774918469021,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014608","name":"St. Michael\u2019s Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP2- DA040256"],"award-info":[{"award-number":["DP2- DA040256"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003400","name":"Ontario Ministry of Research, Innovation and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.17269\/s41997-020-00315-4","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T16:02:49Z","timestamp":1585324969000},"page":"606-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada"],"prefix":"10.17269","volume":"111","author":[{"given":"Nazlee","family":"Maghsoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-2346","authenticated-orcid":false,"given":"Jeanette","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-9386","authenticated-orcid":false,"given":"Dan","family":"Werb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"key":"315_CR1","unstructured":"An Open Letter calling for Public Drug Coverage of High Dose Injectable Hydromorphone for People Who Use Opioids in Ontario. (2019). Retrieved from https:\/\/listhmonodb.wordpress.com\/"},{"key":"315_CR2","unstructured":"Browne, R. (2019). More doctors are prescribing opioids to prevent their patients from dying of overdoses. Global News. Retrieved from https:\/\/globalnews.ca\/news\/5412946\/safe-supply-opioid-overdose\/"},{"key":"315_CR3","unstructured":"Expanding Opioid Substitution Treatment with Managed Opioid Programs. (2019). Toronto: Medical Officer of Health."},{"issue":"38","key":"315_CR4","doi-asserted-by":"publisher","first-page":"E1049","DOI":"10.1503\/cmaj.190344","volume":"191","author":"N Fairbairn","year":"2019","unstructured":"Fairbairn, N., Ross, J., Trew, M., Meador, K., Turnbull, J., MacDonald, S., et al. (2019). Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline. CMAJ, 191(38), E1049\u2013E1056.","journal-title":"CMAJ"},{"key":"315_CR5","unstructured":"Government of Canada approves new treatment options for opioid use disorder and supports research, treatment and harm reduction projects in Ontario. [Press release]. Retrieved from https:\/\/www.canada.ca\/en\/health-canada\/news\/2019\/05\/government-of-canada-approves-new-treatment-options-for-opioid-use-disorder-and-supports-research-treatment-and-harm-reduction-projects-in-ontario.html"},{"key":"315_CR6","unstructured":"Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder. (2017). Retrieved from https:\/\/www.bccsu.ca\/wp-content\/uploads\/2017\/10\/BC-iOAT-Guidelines-10.2017.pdf"},{"key":"315_CR7","unstructured":"National Report: Apparent opioid-related deaths in Canada. (2019). Retrieved from https:\/\/health-infobase.canada.ca\/datalab\/national-surveillance-opioid-mortality.html#AORD"},{"issue":"5","key":"315_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","volume":"73","author":"E Oviedo-Joekes","year":"2016","unstructured":"Oviedo-Joekes, E., Guh, D., Brissette, S., Marchand, K., MacDonald, S., Lock, K., et al. (2016). Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial. JAMA psychiatry, 73(5), 447\u2013455.","journal-title":"JAMA psychiatry"},{"key":"315_CR9","unstructured":"Policy Guide: Injectable hydromorphone maintenance treatment. (2018). Retrieved from http:\/\/library.bcpharmacists.org\/6_Resources\/6-2_PPP\/1049-PPP67_Policy_Guide_iOAT.pdf"},{"key":"315_CR10","unstructured":"Rai, N., Sereda, A., Hales, J., Kolla, G. (2019.). Urgent call on clinicians: prescribe alternatives to poisoned drug supply. Retrieved from https:\/\/healthydebate.ca\/opinions\/safer-supply-opioids"},{"key":"315_CR11","unstructured":"Safe Supply Concept Document. (2019). Retrieved from https:\/\/vancouver.ca\/files\/cov\/capud-safe-supply-concept-document.pdf"},{"issue":"1","key":"315_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","volume":"207","author":"J Strang","year":"2015","unstructured":"Strang, J., Groshkova, T., Uchtenhagen, A., van den Brink, W., Haasen, C., Schechter, M. T., et al. (2015). Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. Br J Psychiatry, 207(1), 5\u201314.","journal-title":"Br J Psychiatry"},{"key":"315_CR13","unstructured":"WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users: 2012 revision. (2012). Retrieved from Geneva: https:\/\/www.who.int\/hiv\/pub\/idu\/targets_universal_access\/en\/"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-020-00315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.17269\/s41997-020-00315-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-020-00315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:05:22Z","timestamp":1616803522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.17269\/s41997-020-00315-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.17269\/s41997-020-00315-4","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}